Cerevel Therapeutics Holdings Price on March 13, 2024
If you're considering investing in Cerevel Stock, it is important to understand the factors that can impact its price. We have found twenty-one technical indicators for Cerevel Therapeutics Holdings, which you can use to evaluate the volatility of the firm. Please confirm Cerevel Therapeutics' Downside Deviation of 1.05, mean deviation of 0.7719, and Risk Adjusted Performance of 0.0551 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Cerevel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cerevel |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CERE |
Based on monthly moving average Cerevel Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cerevel Therapeutics by adding Cerevel Therapeutics to a well-diversified portfolio.
Related Headline
Design Therapeutics Headline on 13th of March 2024
Filed transaction by Design Therapeutics Officer: Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Cerevel Therapeutics Valuation on March 13, 2024
It is possible to determine the worth of Cerevel Therapeutics on a given historical date. On March 13, 2024 Cerevel was worth 41.96 at the beginning of the trading date compared to the closed value of 42.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cerevel Therapeutics stock. Still, in general, we apply an absolute valuation method to find Cerevel Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cerevel Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cerevel Therapeutics' related companies.
Open | High | Low | Close | Volume | |
41.33 | 42.05 | 41.33 | 41.88 | 1,556,951 | |
03/13/2024 | 41.96 | 42.29 | 41.88 | 42.21 | 1,519,255 |
42.31 | 42.41 | 42.21 | 42.24 | 1,782,907 |
Backtest Cerevel Therapeutics | | | Cerevel Therapeutics History | | | Cerevel Therapeutics Valuation | Previous | Next |
Cerevel Therapeutics Trading Date Momentum on March 13, 2024
On March 14 2024 Cerevel Therapeutics Holdings was traded for 42.24 at the closing time. The top price for the day was 42.41 and the lowest listed price was 42.21 . The trading volume for the day was 1.8 M. The trading history from March 14, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 0.07% . The overall trading delta against the current closing price is 0.02% . |
Cerevel Therapeutics Fundamentals Correlations and Trends
By evaluating Cerevel Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cerevel Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cerevel financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cerevel Therapeutics Stock history
Cerevel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cerevel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cerevel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cerevel Therapeutics stock prices may prove useful in developing a viable investing in Cerevel Therapeutics
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts. Cerevel Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 258 people.
Cerevel Therapeutics Stock Technical Analysis
Cerevel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Cerevel Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Cerevel Therapeutics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cerevel Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Cerevel Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cerevel Therapeutics shares will generate the highest return on investment. By undertsting and applying Cerevel Therapeutics stock market strength indicators, traders can identify Cerevel Therapeutics Holdings entry and exit signals to maximize returns
Cerevel Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cerevel Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cerevel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cerevel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0551 | |||
Jensen Alpha | 0.0665 | |||
Total Risk Alpha | (0.12) | |||
Sortino Ratio | (0.04) | |||
Treynor Ratio | 1.02 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Cerevel Stock
If you are still planning to invest in Cerevel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cerevel Therapeutics' history and understand the potential risks before investing.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
CEOs Directory Screen CEOs from public companies around the world |